Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

Abstract

Bloodstream detection of CTC prior to curative-intended liver resection discloses an elevated risk of HCC recurrence and could identify patients, who might benefit from adjuvant treatment.